Core Viewpoint - Service Corporation International (SCI) is expected to show growth in both revenue and earnings for the first quarter of 2025, with revenue estimates at $1.05 billion and earnings per share at 90 cents, reflecting increases from the previous year [1][2]. Group 1: Revenue and Earnings Estimates - The Zacks Consensus Estimate for SCI's revenues is $1.05 billion, indicating a 0.8% increase from the prior-year quarter [1]. - The consensus estimate for quarterly earnings per share is 90 cents, suggesting a 1.1% increase from the figure reported in the year-ago quarter [1]. - The Cemetery segment is projected to generate revenues of $446.4 million, up from $440.6 million in the previous year, while the Funeral segment is expected to contribute $607.3 million, slightly up from $604.7 million [3]. Group 2: Business Model and Strategic Positioning - SCI benefits from a recession-resilient business model and a diverse portfolio, including pre-need and at-need funeral and cemetery services [2]. - Favorable demographics, such as the aging baby boomer population and urbanization trends, position the company well for growth [2]. - Strategic investments in high-growth regions like California, Florida, and Texas, along with acquisitions of funeral homes and cemeteries, enhance SCI's service capabilities [2]. Group 3: Earnings Prediction and Market Position - The current Zacks Rank for SCI is 4 (Sell), and the Earnings ESP is 0.00%, indicating that the model does not predict an earnings beat this time [4]. - The company has a trailing four-quarter negative earnings surprise of 0.6% on average [1].

Boston Beer (SAM) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $1.04 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 176.92%. A quarter ago, it was expected that this brewer would post a loss of $1.18 per share when it actually produced a loss of $1.68, delivering a surprise of -42.37%. Over the last four quarters, the company has s ...

Group 1: Earnings Performance - Middlefield Banc Corp. reported quarterly earnings of $0.60 per share, exceeding the Zacks Consensus Estimate of $0.48 per share, and up from $0.51 per share a year ago, representing an earnings surprise of 25% [1] - The company posted revenues of $18.04 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.59%, compared to year-ago revenues of $16.77 million [2] - Over the last four quarters, Middlefield Banc has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Group 2: Stock Performance and Outlook - Middlefield Banc shares have declined approximately 8.2% since the beginning of the year, slightly better than the S&P 500's decline of 8.6% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.48 on revenues of $17.85 million, and for the current fiscal year, it is $1.96 on revenues of $70.95 million [7] Group 3: Industry Context - The Zacks Industry Rank for Banks - Northeast is currently in the top 22% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5][6]

Core Viewpoint - New Gold (NGD) is expected to report first-quarter 2025 results on April 29, with earnings per share (EPS) estimates showing a shift from a prior anticipated loss to a slight profit, although still reflecting a decline from the previous year [1][3]. Financial Performance - The Zacks Consensus Estimate for NGD's EPS has improved from a loss of four cents to a profit of one cent over the last 60 days, indicating a 50% decline from the year-ago quarter's EPS of two cents [1]. - New Gold has consistently beaten the Zacks Consensus Estimate in the last four quarters, with an average surprise of 79.2% [2]. Market Conditions - Gold prices averaged $2,883.40 per ounce in Q1 2025, a 39% increase year-over-year, driven by geopolitical tensions and strong demand from central banks [3]. - Copper prices rose approximately 19% year-over-year, surpassing $5 per pound in late March due to tariff concerns [4]. Production Expectations - For 2025, New Gold anticipates consolidated gold production of 325,000-365,000 ounces, a 16% increase from the previous year, with Q1 expected to contribute 14% of this total [5]. - Q1 2025 gold production is projected to be between 45,500-51,100 ounces, down from 70,898 ounces in Q1 2024, attributed to significant waste stripping at Rainy River and the depletion of the B3 cave at New Afton [6][12]. - Rainy River's gold production is expected to increase by 20% year-over-year, with Q1 contributing approximately 11% of the annual target [7]. - New Afton's gold output is projected at 60,000-70,000 ounces for 2025, with Q1 production expected between 16,350 and 18,650 ounces [8]. Cost Projections - All-in sustaining costs are expected to be $1,025-$1,125 per ounce in 2025, reflecting a 17% decrease at the midpoint due to higher production and lower operating costs [10]. - Q1 2025 all-in sustaining costs are anticipated to be higher than the $1,396 per ounce reported in Q1 2024, with cash costs also expected to exceed $874 per ounce from the previous year [11]. Stock Performance - New Gold's stock has increased by 93% over the past year, outperforming the industry growth of 42.7% [14].

Core Insights - Vertiv Holdings (VRT) reported strong first-quarter 2025 results, with non-GAAP earnings of 64 cents per share, exceeding estimates by 3.23% and showing a year-over-year increase of 48.8% [1] - Net sales reached $2.04 billion, a 24.2% increase year over year, surpassing estimates by 6.26% [1] Financial Performance - VRT has consistently beaten earnings estimates over the past four quarters, with an average surprise of 10.42% [2] - Organic orders rose 20% year over year, with a book-to-bill ratio of approximately 1.4x, and a backlog of $7.9 billion, up 10% from the end of 2024 and 25% from the previous year [2] Revenue Breakdown - Product revenues, which accounted for 81% of total revenues, increased by 29.9% year over year to $1.65 billion [3] - Service revenues grew 4.7% year over year to $386.3 million [3] - Revenues from the Americas increased 28.1% year over year to $1.19 billion, while APAC revenues surged 34.6% to $447.2 million, and EMEA revenues rose 5.7% to $403.5 million [3][4][5] Operating Details - SG&A expenses rose 10.3% year over year to $346.3 million, but as a percentage of sales, they decreased by 210 basis points to 17% [6] - Adjusted operating profit increased 35.4% year over year to $336.7 million, with a non-GAAP operating margin of 16.5%, up 140 basis points [6] Regional Performance - Adjusted operating profit in the Americas surged 38.3% to $259.7 million, while EMEA's profit increased 11.9% to $78.7 million, and APAC's profit jumped 50.3% to $45.7 million [7] Balance Sheet and Cash Flow - As of March 31, 2025, cash and cash equivalents totaled $1.47 billion, up from $1.23 billion at the end of 2024, while long-term debt slightly decreased to $2.904 billion [8] - Cash flow from operating activities was $303.3 million, down from $425.2 million in the prior quarter, with free cash flow at $265 million [9] 2025 Guidance - For 2025, VRT expects revenues between $9.325 billion and $9.575 billion, with organic net sales growth projected between 16.5% and 19.5% [10] - Adjusted operating profit is anticipated to be between $1.885 billion and $1.985 billion, with an operating margin of 19.75-21.25% [10] - Non-GAAP earnings per share are expected to range from $3.45 to $3.65, indicating a year-over-year growth of 21.75% [10] Second Quarter Outlook - For Q2 2025, revenues are expected between $2.325 billion and $2.375 billion, with organic net sales growth projected between 19% and 23% [11] - Adjusted operating profit is anticipated to be between $420 million and $450 million, with an operating margin in the 18-19% range [11] - Non-GAAP earnings per share for Q2 are expected to be between 77 cents and 85 cents, suggesting year-over-year growth of 29.85% [12]

Core Viewpoint - Cardiff Oncology is expected to report a year-over-year increase in earnings despite lower revenues, with the actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $0.19 per share, reflecting a year-over-year change of +13.6% [3]. - Revenues are projected to be $0.17 million, down 19.1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 9.52% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for Cardiff Oncology is higher than the Zacks Consensus Estimate, leading to an Earnings ESP of +24.32% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Cardiff Oncology currently holds a Zacks Rank of 2, suggesting a high likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Cardiff Oncology was expected to post a loss of $0.25 per share but delivered a loss of $0.21, resulting in a surprise of +16% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [13]. Conclusion - Cardiff Oncology is positioned as a compelling earnings-beat candidate, but investors should consider other factors influencing stock performance beyond earnings results [16].

Core Viewpoint - The market anticipates a year-over-year decline in Esab's earnings due to lower revenues, with a focus on how actual results compare to estimates to influence stock price [1][2]. Earnings Expectations - Esab is expected to report quarterly earnings of $1.18 per share, reflecting a -1.7% change year-over-year, with revenues projected at $630.56 million, down 8.6% from the previous year [3]. - The consensus EPS estimate has been revised 1.32% lower in the last 30 days, indicating a bearish sentiment among analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Esab is lower than the consensus estimate, resulting in an Earnings ESP of -2.54%, suggesting a challenging outlook for beating estimates [10][11]. - Esab currently holds a Zacks Rank of 3, complicating predictions for an earnings beat [11]. Historical Performance - In the last reported quarter, Esab exceeded expectations by delivering earnings of $1.28 per share against an estimate of $1.15, resulting in a surprise of +11.30% [12]. - Over the past four quarters, Esab has consistently beaten consensus EPS estimates [13]. Conclusion - While Esab does not appear to be a strong candidate for an earnings beat, investors should consider other factors influencing stock performance ahead of the earnings release [16].

Amgen (AMGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 1. On the oth ...

The market expects Biogen Inc. (BIIB) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 1, 2025, might help the stock move higher if these key numbers are better ...

BJ's Restaurants (BJRI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on May 1, 2025, might help the stock move higher if these key numbers are better than e ...